eric topol glp 1 A new review of the GLP-1 receptor drugs @NEJM https://t.co/PK03jApZWB surprisingly, the word inflammation only appears once, in this diagram Dr. Eric Topol: Pushing Medicine
Description
Supplement manufacturers have capitalized on the explosive popularity of diabetes control and weight loss drugs such as Ozempic, Wegovy and Zepbound by flooding the market with their own pills,...
However, the incidence of CRC was not significantly associated with GLP-1 RA use compared with other drugs (OR, 1.73
In addition, there will be a $350 million up-front payment as Abbvie takes over the reins of GUB-014295 (referred to as Gubamy), a long-acting analog of the satiety hormone amylin, currently in phase I development.
What role do you see oral GLP-1s playing in formulary strategy
Discover how pairing GLP-1 weight loss with aesthetic treatments like fillers & skin tightening creates a harmonious, natural beauty transformation
